Supplement-drug interactions
This article was originally published in The Tan Sheet
Executive Summary
"Potentially severe drug-dietary supplement interactions were infrequent and comparable in incidence to potentially serious drug-drug interactions" in a population of 458 veteran outpatients from VA centers in Pittsburgh and Los Angeles, according to a study published in the March 22 Archives of Internal Medicine. Of 89 potential drug-supplement interactions identified, 6% were classified as severe, say Catherine Peng, Veterans Affairs Pittsburgh Healthcare System, et al. Most of the potential interactions identified were with ginseng, garlic, ginkgo, and coenzyme Q-10. Authors note 43% of the patients were taking at least one supplement with Rx medications...
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.